Resources

We undertook this study to examine rural-specific contextual factors that affect the day-to-day experiences of PWUD.

We investigated drug use-related stigma as a correlate of using opioids while alone frequently (very often vs.

Using a person-centered approach, this study evaluates patterns of treatment barriers and the factors associated with experiencing distinct sets of barriers among women.

Arts-based interventions are ideal participatory action approaches that can empower young people to be active agents in substance use prevention.

We examined competing risks and drivers of solitary drug use (SDU), as well as harm reduction strategies implemented during SDU episodes, among women who inject drugs.

We discuss the best available evidence regarding virtual overdose monitoring services as an additional option for enhancing timely access to harm reduction and overdose response, and describe our i

There is limited data on psychostimulant use for various racial and ethnic groups, including Black people, and the challenges they face living as minorities overcoming historical challenges includi

We examined associations between discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain, stratified by diagnosed OUD and prescribe

Community drug checking is an emerging response to the overdose crisis. However, stigma has been identified as a potential barrier to service use that requires investigation.

To investigate the association between pharmacotherapies and hospitalization and mortality outcomes in persons with amphetamine or methamphetamine use disorder.

The objective of this study was to determine the number of drug checking samples containing fentanyl and fentanyl analogues using both point of care and confirmatory drug checking technologies.

We aimed to determine: (i) the toxicological profile of cocaine, metabolites and adulterants amongst three groups of cocaine-related fatalities in which cocaine and/or metabolites were present in b

This review aims to describe telemedicine-delivered substance use disorder (SUD) treatments and services along the cascade of care in the U.S. after the start of the COVID-19 pandemic.

Understanding the geographic variations in fatal overdose mortality is necessary to avoid disproportionate risk resulting from service access inequity.